NEW POST
Imagin Medical Announces Appointment of Kayvon Namvar to Board of Directors and Kevin Slawin, M.D. as Board Chairman
Vancouver, B.C. and Boston, MA, November 8, 2021 – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) “Imagin” or the “Company”), a surgical imaging company visualizing cancer in vital new ways…
Read More
Rapha Capital Leads New $3 Million Convertible Note Financing in Imagin Medical, Inc.
Rapha Capital BioVentures Fund I, LP (RCBVFI) managed by Rapha Capital leads the financing. Kevin Slawin, M.D., a leading urooncologist and manager of RCBVFI, joins the board. Imagin Medical's i/Blue™…
Read More
IMAGIN MEDICAL Secures New $3 Million Convertible Note Financing
Rapha Capital BioVentures Fund I, LP (RCBVFI), Leads New Convertible Note Financing Kevin Slawin, MD, a Leading UroOncologist and Manager of RCBVFI Joins the Board Imagin Medical’s i/Blue™ Imaging System is…
Read More
InvestorNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) to Demonstrate Advanced Capabilities of i/Blue Imaging System(TM) at AUA Annual Meeting
Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company focused on establishing a new standard of care in visualizing cancer during minimally invasive procedures, today announced that the final…
Read More
Imagin Medical Reports Company on Schedule for American Urology Association Demonstration
Vancouver, B.C. and Boston, MA, August 17, 2021 – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported that the final…
Read More
InvestorNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Poised to Establish New Standard in Bladder Cancer Visualization
Imagin Medical (CSE: IME) (OTCQB: IMEXF) has developed the i/Blue Imaging System(TM), an innovative technology designed to significantly improve the way surgeons visualize cancerous cells for more accurate bladder resection.…
Read More
Imagin Medical Reports Company on Schedule for Product Demonstration
Vancouver, B.C. and Boston, MA, May 19, 2021 – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported continued progress towards…
Read More
Imain Medical Reports Manufacturing Progress
Vancouver, B.C. and Boston, MA, March 16, 2021 – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported continued progress towards…
Read More
Imagin Medical Closes Second Tranche of Convertible Note Offering
Vancouver, B.C. and Boston, MA, Feb. 18, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD3) (“Imagin” or the “Company”)…
Read More
Imagin Medical Builds Momentum for 2021
VANCOUVER, British Columbia, and BOSTON, Jan. 13, 2021 -- via InvestorWire – Imagin Medical (CSE: IME) (OTC: IMEXF) (FRA: DPD2) (the “Company”) announces that critical milestones met in the second…
Read More
Imagin Medical Engages Torrey Hills Capital
VANCOUVER, British Columbia, and BOSTON, Jan. 20, 2021 – via InvestorWire – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (FSE: DPD2) ("Imagin" or the "Company") is pleased to announce that…
Read More
Imagin Medical Closes First Tranche of Convertible Notes Offering
Vancouver, B.C. and Boston, MA, November 10, 2020 – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that, further to…
Read More
Imagin Medical Announces Agenda for KOL Virtual Investor Event on October 29, 2020
Vancouver, B.C. and Boston, MA, October 26, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced the agenda for its…
Read More
Imagin Medical Announces Proposed Offering of $3 Million of Convertible Notes and Share Consolidation
Vancouver, B.C. and Boston, MA, October 22, 2020 – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced its intention to:…
Read More
Imagin Medical Selects Lighthouse Imaging as i/Blue Imaging System Contract Manufacturer
Vancouver, B.C. and Boston, MA, October 7, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that it has selected…
Read More
Imagin Medical to Host KOL Webcast Event on October 29, 2020
Vancouver, B.C. and Boston, MA, September 29, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that it will host…
Read More
Imagin Medical Reports Fiscal 2020 Third Quarter Results
Vancouver, B.C. and Boston, MA, August 28, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for the…
Read More
Imagin Medical To Begin Testing of i/Blue Imaging System on Anatomical Bladder Models
- New Video, Podcast Episode Available on Imagin Medical’s Website - Vancouver, B.C. and Boston, MA, July 15, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol:…
Read More
Imagin Medical Imagin Medical Reports Fiscal 2020 Second Quarter Results
Vancouver, B.C. and Boston, MA, May 28, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for the…
Read More
Imagin Medical To Report Second Fiscal Quarter 2020 Financial Results on May 28, 2020 – Conference Call
Vancouver, B.C. and Boston, MA, May 21, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) announced today that its financial results…
Read More
Imagin Medical Announces Successful Delivery of Functional i/Blue Imaging System
Vancouver, B.C. and Boston, MA, May 21, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that its contract design…
Read More
Imagin Medical Reports Response to Covid-19
Vancouver, B.C. and Boston, MA, May 14, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today provided an update on the…
Read More
Imagin Medical Supports Cancer Awareness Month
Vancouver, B.C. and Boston, MA, May 12, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) announces its support of Bladder Cancer…
Read More
Imagin Medical Receives Approval to Reprice and Extend Term of Warrants
Vancouver, B.C. and Boston, MA, April 9, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) announces that it has received approval…
Read More
Imagin Medical Reports Physician Feedback on i/Blue Imaging System for Bladder Cancer Visualization
Vancouver, B.C. and Boston, MA, March 10, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported ongoing market research feedback…
Read More
Imagin Medical Reports Fiscal 2020 First Quarter Results
Vancouver, B.C. and Boston, MA, February 27, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for the…
Read More
Imagin Medical to Report First Fiscal Quarter 2020 Financial Results on February 27, 2019 – Conference Call to Follow
Vancouver, B.C. and Boston, MA, February 20, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) announced today that its financial results…
Read More
Imagin Medical to Present at NobleCon16
Vancouver, B.C. and Boston, MA, February 10, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) announced today that its President and…
Read More
Imagin Medical Finishes 2019 Strong and Provides Insight into 2020 and Beyond
Vancouver, B.C. and Boston, MA, January 23, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today provided a corporate update to…
Read More
Imagin Medical Closes Oversubscribed Private Placement
Vancouver, B.C. and Boston, MA, January 21, 2020 – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that, further to…
Read More
Imagin Medical Announces Stock Option Grant
Vancouver, B.C. and Boston, MA, January 10, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced today that, pursuant to…
Read More
Imagin Medical Reports Successful Completion of Design Verification and Announces Private Placement
Vancouver, B.C. and Boston, MA, January 8, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that it completed design…
Read More
Imagin Medical Reports Fiscal Year End 2019 Results
Vancouver, B.C. and Boston, MA, December 24, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for its…
Read More
Imagin Medical Announces Results of Annual Meeting of Shareholders
Vancouver, B.C. and Boston, MA, December 18, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) is pleased to announce the results…
Read More
Imagin Medical to Present at the First Annual BIOTuesdays Pre-JPM Virtual Conference
Vancouver, B.C. and Boston, MA, December 3, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that management will present…
Read More
Imagin Medical Announces Social Media Campaign Launch
Vancouver, B.C. and Boston, MA, – October 17, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) is pleased to announce the…
Read More
Imagin Medical Announces Meeting Regarding i/Blues’s Regulatory Pathway
Vancouver, B.C. and Boston, MA, September 26, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced it recently met with…
Read More
Imagin Medical Reports Fiscal 2019 Third Quarter Results
Vancouver, B.C. and Boston, MA, August 27, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for the…
Read More
Imagin Medical Progress Update
Vancouver, B.C. and Boston, MA, July 15, 2019 – Imagin Medical (CSE: IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reportedcontinued progress toward verification of its…
Read More
Imagin Medical Announces Stock Option Grant
Vancouver, B.C. and Boston, MA, June 24, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced that, under its stock option plan, it…
Read More
Imagin Medical Reports Fiscal 2019 Second Quarter Financial Results
Vancouver, B.C. and Boston, MA, June 11, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for the…
Read More
Imagin Medical to Report Fiscal 2019 Second Quarter Results on June 11, 2019 – Conference Call to Follow
Vancouver, B.C. and Boston, MA, June 3, 2019 – Imagin Medical (CSE: IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”), an emerging leaderin the development and commercialization…
Read More
Imagin Medical Welcomes World-Renowned Bladder Cancer Expert Dr. Ashish Kamat to Its Scientific Board of Advisors
Vancouver, B.C. and Boston, MA, April 17, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that Dr. Ashish M.…
Read More
Imagin Medical Completes Assembly of i/Blue Imaging Functional Unit
Vancouver, B.C. and Boston, MA, February 27, 2019 – Imagin Medical (CSE: IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reportedfinancial results for the three months…
Read More
Imagin Medical to Report Fiscal Q1 2019 Results on February 27, 2019 – Conference Call to Follow
Vancouver, B.C. and Boston, MA, February 19, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”), an emerging leader in the development…
Read More
Imagin Medical to Present at Noble Capital Markets 15th Annual Investor Conference
Vancouver, B.C. and Boston, MA, January 23, 2018 – Imagin Medical (CSE: IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”), an emerging leader in the development and…
Read More
Imagin Medical Posts New Presentation on Its Website
Vancouver, B.C. and Boston, MA, January 9, 2018 – Imagin Medical (CSE: IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that, ahead of its planned…
Read More
Imagin Medical Reports Fiscal Year End 2018 Results
Vancouver, B.C. and Boston, MA, December 20, 2018 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for the…
Read More
Imagin Medical Announces Results of Annual Meeting of Shareholders
Vancouver, B.C. and Boston, MA, December 18, 2018 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) is pleased to announce the results…
Read More
Imagin Medical Comments on Recent Promotional Activity Pursuant to OTC Markets Request
Vancouver, B.C. and Boston, MA, November 28, 2018 – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) wishes to make the following…
Read More
Imagin Medical Receives Approximately $1 from Exercise of Warrants
Vancouver, B.C. and Boston, MA, October 31, 2018 – Imagin Medical (CSE: IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) announced today that it has received proceeds…
Read More
Imagin Medical Announces Changes to its Board of Directors
Vancouver, B.C. and Boston, MA, October 2, 2018 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) announced that Steven Chan has resigned…
Read More
Imagin Medical Reports Fiscal 2018 Third Quarter Results
Vancouver, B.C. and Boston, MA, August 14, 2018 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for the…
Read More
Imagin Medical Announces Stock Options Granted
Vancouver, B.C. and Boston, MA, July 25, 2018 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today that, pursuant to the Company’s Stock…
Read More
Imagin Medical Reports Research Study Progress
Vancouver, B.C. and Boston, MA, July, 17, 2018 – Imagin Medical (CSE: IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) announced todayfavorable results in the 10-subject investigator-sponsored…
Read More
Imagin Medical Announces Uplisting to OTCQB
Vancouver, BC and Boston, MA, June 27, 2018 – Imagin Medical (CSE: IME) (OTCPINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) is pleased to announce that its…
Read More
Imagin Medical Provides Further Details on Kilmer Lucas Engagement
Vancouver, BC and Boston, MA, June 22, 2018 – Imagin Medical (CSE: IME) (OTCPINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) is pleased to provide, in addition…
Read More
Imagin Engages Kilmer Lucas for Cross-border Investor Relations
Vancouver, BC and Boston, MA, June 20, 2018 – Imagin Medical (CSE: IME) (OTCPINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that it has engaged…
Read More
Imagin Gains Momentum; Positive Progress in Research Study
Vancouver, B.C. and Boston, MA, April 26, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) is providing the following update on the…
Read More
IME Closes Oversubscribed Private Placement
Vancouver, B.C. and Boston, MA, April 19, 2018 – Imagin Medical, Inc. (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announces that, further to its press releases…
Read More
Imagin Medical Closing Private Placement
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive…
Read More
Imagin Medical Announces Private Placement
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive…
Read More
Imagin Medical Closes Private Placement
Vancouver, B.C. and Boston, MA, March 8, 2018 – Imagin Medical Inc. (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today the closing of a…
Read More
Imagin Medical Product Re-Design on Schedule
Vancouver, B.C. and Boston, MA, March 7, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”), announced today that the Company expects the…
Read More
Imagin Medical Announces Private Placement
Vancouver, B.C. and Boston, MA, March 1, 2018 – Imagin Medical Inc. (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today the offering of a…
Read More
Imagin Medical Appoints Director of Regulatory Affairs
Vancouver, B.C. and Boston, MA, February 26, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”), announced today the Company has hired Pam…
Read More
Imagin Medical Closes Private Placement
Vancouver, B.C. and Boston, MA, February 15, 2018 – Imagin Medical Inc. (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today the closing of a…
Read More
American Urological Association (AUA) Honors Imagin Medical Scientific Advisor
Vancouver, B.C. and Boston, MA, February 9, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”), announced today that the lead investigator on…
Read More
University of Rochester Initial Research Study Patients Completed
Vancouver, B.C. and Boston, MA, February 7, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”), as a follow-up to the announcement dated…
Read More
John Vacha Joins Imagin Medical Board of Directors
Vancouver, B.C. and Boston, MA, January 30, 2018– Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that John Vacha, the Company’s recently appointed…
Read More
Imagin Medical Announces Private Placement
Vancouver, B.C. and Boston, MA, January 30, 2018 – Imagin Medical Inc. (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today the offering of a…
Read More
Imagin Medical Research Study Begins
Vancouver, B.C. and Boston, MA, January 9, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today that pursuant to the Company’s…
Read More
Imagin Medical Stock Options Granted
Vancouver, B.C. and Boston, MA, January 17, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today that pursuant to the Company’s…
Read More
Imagin Medical Recruits Senior Healthcare CFO
Vancouver, B.C. and Boston, MA, January 15, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today that it hired John Vacha…
Read More
Imagin Medical Stock Option Granted
Vancouver, B.C. and Boston, MA, January 9, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today that pursuant to the Company’s…
Read More
Imagin Medical Builds Momentum for 2018
Vancouver, B.C. and Boston, MA, January 9, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced that critical milestones were met in…
Read More
Imagin Medical Stock Options Granted
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in detecting cancers and visualizing the surgical field in…
Read More
Imagin Medical Investors Exercise Warrants Generating $1M
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in detecting cancers and visualizing the surgical field in…
Read More
Imagin Medical Opens Enrollment for Research Study
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in detecting cancers and visualizing the surgical field in…
Read More
Imagin Medical Stock Options Granted
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in detecting cancers and visualizing the surgical field in…
Read More
Prototype Redesign
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in detecting cancers and visualizing the surgical field in…
Read More
Enhanced Cystoscopy Improves Bladder Cancer Detection
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in detecting cancers and visualizing the surgical field in…
Read More
Imagin Medical Scientific Advisor Attends Society of International Urology Meeting
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in detecting cancers and visualizing the surgical field in…
Read More
Imagin Medical Announces Stock Options Granted
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in detecting cancers and visualizing the surgical field in…
Read More
Imagin Medical Announces PP for Communications
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in detecting cancers and visualizing the surgical field in…
Read More
Imagin Medical Announces Clinical Research Criteria
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in detecting cancers and visualizing the surgical field in…
Read More
Imagin Medical Closed $1M Private Placement
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive…
Read More
Imagin Medical Closing 2nd and Final Tranche of $1M Private Placement
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive…
Read More
Urologists Invest in Imagin Medical Private Placement
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive…
Read More
Clinical Research Study Listed on Government Website
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive…
Read More
Imagin Medical Closing Tranche 1 and Increasing Private Placement Offering
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive…
Read More
Imagin Medical Receives 1st In-Human Research Study Approval
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive…
Read More
Imagin Medical Announces Private Placement
Vancouver, B.C. and Boston, MA, September 26, 2017 – Imagin Medical, Inc. (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today the offering of a non-brokered…
Read More
2017 Mid Year Update
Vancouver, B.C. and Boston, MA, June 28, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) released today a mid-year report to keep investors…
Read More
New Release – Imagin Medical Grants Stock Options
Vancouver, B.C. and Boston, MA, April 10, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today that pursuant to the Company’s…
Read More
Imagin Medical Closes Private Placement of Convertible Notes
Vancouver, B.C. and Boston, MA, March 3, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that it has closed the private…
Read More
Imagin Medical Arranges Private Placement of Convertible Notes
Vancouver, B.C. and Boston, MA, February 24, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that it will issue on a…
Read More
Imagin Medical Signs $8M Term Sheet with New York Private Equity Firm Alumina Partners LLC
Vancouver, B.C. and Boston, MA, February 22, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that it has executed a non-binding…
Read More
Imagin Medical Technology Presented at Photonics West 2017
Vancouver, B.C. and Boston, MA, February 9, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that the i/Blue Imaging System technology…
Read More
Imagin Medical Final Product Design on Track
Vancouver, B.C. and Boston, MA, March 2, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that the Company and Optel, Inc.,…
Read More
Imagin Medical Poised for 2017 Success
Vancouver, B.C. and Boston, MA, January 10, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that, during 2016, the Company laid…
Read More
Imagin Medical Closes Tranche 2 of Private Placement
Vancouver, B.C. and Boston, MA, December 9 , 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that, further to its press…
Read More
Imagin Medical Chooses Optel, Inc. to Design i/Blue Prototype for Commercialization
Vancouver, B.C. and Boston, MA, December 8, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that it is partnering with Optel,…
Read More
Imagin Medical Completes Alpha B Prototype
Vancouver, B.C. and Boston, MA, December 1, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that it has completed development of…
Read More
Dr. Roger Buckley Joins Imagin Medical’s Scientific Board of Advisors
Vancouver, B.C. and Boston, MA, November10, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that Dr. Roger J. Buckley, has joined…
Read More
Dr. Liam J. Hurley Joins Imagin Medical’s Scientific Board of Advisors
Vancouver, B.C. and Boston, MA, October 27, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that Dr. Liam J. Hurley, a…
Read More
Imagin Medical Closes Tranche 1 of Private Placement for $385,000
Vancouver, B.C. and Boston, MA, October 20, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that, further to its September 13,…
Read More
Imagin Medical’s Quality Management System Initial Phase Complete
Vancouver, B.C. and Boston, MA, October 6, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that the Company’s Quality Plan for…
Read More
Ken Daignault Joins Imagin Medical’s Board of Directors
Vancouver, B.C. and Boston, MA, September 29, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that Ken Daignault has joined Imagin’s…
Read More
Dr. Edward Messing, Chief of Urology, U Rochester Medical Center Joins Imagin Medical’s Scientific Board of Advisors
Vancouver, B.C. and Boston, MA, September 22 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that Dr. Edward Messing, Chair of Urology,…
Read More
Disruptive Technology Update
Vancouver, B.C. and Boston, MA, September 15, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) As a follow up to Imagin’s announcement of…
Read More
Imagin Medical Issues Private Placement
Vancouver, B.C. and Boston, MA, September 13, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today its intention to undertake a non-brokered…
Read More
American Urological Association’s New Guidelines for Bladder Cancer Support Imagin Medical’s Objective
Vancouver, B.C. and Boston, MA, August 1, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) is announcing that the recent publication of the…
Read More
Alpha Prototype on Schedule
Vancouver, B.C. and Boston, MA, July 20, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that the process of retrofitting and…
Read More
Imagin Signs Agreements to Support i/Blue Development: University of Rochester Laboratory of Laser Energetics and U.S. Department of Energy
Vancouver, B.C. and Boston, MA, June 9, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that it has signed a Collaborative…
Read More
Imagin Attended American Urological Association Annual Meeting
Vancouver, B.C. and Boston, MA, May 24, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”), as previously reported, attended the 2016 American…
Read More
Imagin Medical Now Trading on Frankfurt and Stuttgart Exchanges
Vancouver, B.C. and Boston, MA, May 10, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (the “Company”) is pleased to announce that its common shares now trade on the…
Read More
Imagin Medical Attends America Urology Association Annual Meeting
Vancouver, B.C. and Boston, MA, May 5, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (the “Company”) announced that President and CEO, Jim Hutchens, will be attending the 2016…
Read More
Imagin Medical Begins Trading on OTC
Vancouver, B.C. and Boston, MA, April 28, 2016 – Imagin Medical (CSE: IME) (OTC PINK:IMEXF) (the “Company”) announced that it has started trading on the OTC Pinksheets under the symbol…
Read More
Imagin Announces Dr. Ralph deVere White Named Chairman of the Scientific Advisory Board
Vancouver, B.C. and Boston, MA, April 26, 2016 – Imagin Medical (CSE: IME) (the “Company”) is pleased to announce that Ralph deVere White, M.D., has accepted the position of Chairman…
Read More
Imagin Announces i/Blue Product Development Program Moves to University of Rochester Laboratory for Laser Energetics (LLE)
Vancouver, B.C. and Boston, MA, April 12, 2016 – Imagin Medical (CSE: IME) (the “Company”) announced today that Dr. Stavros Demos, the inventor of the i/Blue Imaging System, has accepted…
Read More
Imagin Corporate Update – Prototype Development Launched with Boston Management Team
Vancouver, B.C., March 9, 2016 – Imagin Medical (CSE: IME) (the “Company”) is pleased to report it has begun development of its ultrasensitive i/Blue Imaging System. To be successful in…
Read More
Imagin Medical Starts Trading On the CSE
Vancouver, B.C., February 23, 2016 – Imagin Medical Inc. (formerly Expedition Mining Inc.) announces that further to its news release dated February 10, 2016, the Canadian Securities Exchange (“CSE”) has…
Read More
Acquisition Closing
Vancouver, B.C., February 10, 2016 – Expedition Mining Inc. (EXU) announces the closing of the private placement of $1,000,000 which completes the acquisition of BSS Life Sciences Inc., (herein to…
Read More
AGM results
Vancouver, B.C., December 10, 2015 –Expedition Mining Inc. (“EXU” or the “Company”) (CSE: EXU) is pleased to announce that at its Annual and Special Shareholders Meeting held on December 8,…
Read More
Update on Transaction with BSS
Vancouver, B.C., November 18, 2015 – Further to its press release of October 5, 2015, Expedition Mining Inc. (“EXU” or the “Company”) (CSE: EXU) provides an update on the status…
Read More